“…Numerous reports have described the development of TeNT neutralizing mAbs from either murine or human origin (Fitzsimmons et al, 2000;Scott et al, 2010;Wang et al, 2016). Most, if not all, of the neutralizing mAbs reported could not individually alone completely neutralize the TeNT in vivo (Fitzsimmons et al, 2000;Matsuda et al, 1992;Sadreddini et al, 2015;Scott et al, 2010;Wang et al, 2016;Yousefi et al, 2014bYousefi et al, , 2016 unless high doses of single antibodies were used (Arunachalam et al, 1992;Chin et al, 2003;Kamei et al, 1990;Lang et al, 1993;Volk et al, 1984;Yousefi et al, 2014a). To date, development of a safer and highly efficacious mAb that provides effective protection against tetanus remains a challenging goal.…”